These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 16925452

  • 1. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program.
    Hamer AM, Hartung DM, Haxby DG, Ketchum KL, Pollack DA.
    J Manag Care Pharm; 2006; 12(6):449-56. PubMed ID: 16925452
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of cost savings to a state Medicaid program following a sertraline tablet-splitting program.
    Vuchetich PJ, Garis RI, Jorgensen AM.
    J Am Pharm Assoc (2003); 2003; 43(4):497-502. PubMed ID: 12952314
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Implications of an SSRI generic step therapy pharmacy benefit design: an economic model in anxiety disorders.
    Panzer PE, Regan TS, Chiao E, Sarnes MW.
    Am J Manag Care; 2005 Oct; 11(12 Suppl):S370-9. PubMed ID: 16236019
    [Abstract] [Full Text] [Related]

  • 5. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK, Kruzikas DT, McLaughlin TP.
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center.
    Dobscha SK, Anderson TA, Hoffman WF, Winterbottom LM, Turner EH, Snodgrass LS, Hauser P.
    Psychiatr Serv; 2003 Feb; 54(2):195-200. PubMed ID: 12556600
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures.
    Dewa CS, Hoch JS, Goering P.
    Clin Ther; 2001 Feb; 23(2):292-306. PubMed ID: 11293562
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.
    Russell JM, Berndt ER, Miceli R, Colucci S, Grudzinski AN.
    Am J Manag Care; 1999 May; 5(5):597-606. PubMed ID: 10537866
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM, Brown EB, Gonzales JS, Munir R.
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants.
    Wu E, Greenberg P, Yang E, Yu A, Ben-Hamadi R, Erder MH.
    Curr Med Res Opin; 2008 Oct; 24(10):2805-13. PubMed ID: 18755054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.